Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeholdingselskabet Jørgen Darling Jensen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   4.1% 13.4% 24.7% 29.1% 15.8% 11.7% 19.2% 19.2%   Credit score (0-100)   51 18 3 1 11 19 7 7   Credit rating   BBB BB B C BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,112 1,230 -9.2 -9.9 1,244 1,297 0.0 0.0   EBITDA   335 86.4 -6.3 -9.9 296 266 0.0 0.0   EBIT   300 54.4 -6.3 -9.9 296 266 0.0 0.0   Pre-tax profit (PTP)   287.2 50.4 -10.6 -12.1 296.7 268.8 0.0 0.0   Net earnings   223.3 39.2 -8.3 -9.4 231.5 209.7 0.0 0.0   Pre-tax profit without non-rec. items   287 50.4 -10.6 -12.1 297 269 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   284 123 115 105 337 271 21.4 21.4   Interest-bearing liabilities   303 72.9 82.0 1.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   772 368 202 111 422 381 21.4 21.4   Net Debt   -245 -77.6 -116 -105 -99.3 -63.2 -21.4 -21.4     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,112 1,230 -9.2 -9.9 1,244 1,297 0.0 0.0   Gross profit growth   0.4% 10.7% 0.0% -7.7% 0.0% 4.3% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   772 368 202 111 422 381 21 21   Balance sheet change%   18.7% -52.3% -45.2% -44.8% 279.0% -9.7% -94.4% 0.0%   Added value   335.3 86.4 -6.3 -9.9 295.9 266.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -70 -67 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.0% 4.4% 68.4% 100.0% 23.8% 20.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   42.3% 9.5% -2.2% -6.4% 111.7% 67.0% 0.0% 0.0%   ROI %   58.4% 13.9% -3.2% -6.6% 134.4% 88.4% 0.0% 0.0%   ROE %   82.0% 19.3% -7.0% -8.6% 104.8% 69.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   36.8% 33.4% 56.9% 94.6% 79.9% 71.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -73.1% -89.8% 1,839.7% 1,058.8% -33.6% -23.8% 0.0% 0.0%   Gearing %   106.9% 59.3% 71.5% 1.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 2.1% 5.6% 5.2% 160.3% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.5 1.5 2.3 18.5 5.0 3.5 0.0 0.0   Current Ratio   1.5 1.5 2.3 18.5 5.0 3.5 0.0 0.0   Cash and cash equivalent   548.3 150.6 198.0 106.2 99.3 63.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   248.8 122.9 114.7 105.2 336.7 271.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   335 86 -6 -10 296 266 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   335 86 -6 -10 296 266 0 0   EBIT / employee   300 54 -6 -10 296 266 0 0   Net earnings / employee   223 39 -8 -9 231 210 0 0